BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22959745)

  • 21. Comprehensive analysis on phenotype and genetic basis of Chinese Fanconi anemia patients: dismal outcomes call for nationwide studies.
    Nie D; Zhang J; Wang F; Zhang W; Liu L; Chen X; Zhang Y; Cao P; Xiong M; Wang T; Wu P; Ma X; Tian W; Wang M; Chen KN; Liu H
    BMC Med Genet; 2020 Jun; 21(1):118. PubMed ID: 32487094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fanconi anemia: a single center experience of a large cohort.
    Kesici S; Ünal Ş; Kuşkonmaz B; Aytaç S; Çetin M; Gümrük F
    Turk J Pediatr; 2019; 61(4):477-484. PubMed ID: 31990462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of malignancy and clonal chromosomal abnormalities in Fanconi anemia.
    Vundinti BR; Korgaonkar S; Ghosh K
    Indian J Cancer; 2010; 47(4):397-9. PubMed ID: 21131752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fanconi anaemia: genetics, molecular biology, and cancer – implications for clinical management in children and adults.
    Schneider M; Chandler K; Tischkowitz M; Meyer S
    Clin Genet; 2015 Jul; 88(1):13-24. PubMed ID: 25307146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns and frequency of renal abnormalities in Fanconi anaemia: implications for long-term management.
    Sathyanarayana V; Lee B; Wright NB; Santos R; Bonney D; Wynn R; Patel L; Chandler K; Cheesman E; Schindler D; Webb NJA; Meyer S
    Pediatr Nephrol; 2018 Sep; 33(9):1547-1551. PubMed ID: 29651604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility and outcome of haploidentical SCT in pediatric high-risk hematologic malignancies and Fanconi anemia in Uruguay.
    Dufort G; Pisano S; Incoronato A; Castiglioni M; Carracedo M; Pagés C; Simon E; Zuccolo S; Barcelona R; Mezzano R; Tiscornia A; Lemos F; Morosini F; Schelotto M; Giordano H; Carreto E; Bengoechea M; Boggia B; Rodriguez I; Guerrero L; Dabezies A; Castillo L
    Bone Marrow Transplant; 2012 May; 47(5):663-8. PubMed ID: 21765479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retroviral-mediated transduction of the fanconi anemia C complementing (FACC) gene in two murine transplantation models.
    Liu JM; Kim S; Walsh CE
    Blood Cells Mol Dis; 1995; 21(1):56-63. PubMed ID: 7544677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1.
    Navarro S; Meza NW; Quintana-Bustamante O; Casado JA; Jacome A; McAllister K; Puerto S; Surrallés J; Segovia JC; Bueren JA
    Mol Ther; 2006 Oct; 14(4):525-35. PubMed ID: 16859999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spectrum of sequence variations in the FANCA gene: an International Fanconi Anemia Registry (IFAR) study.
    Levran O; Diotti R; Pujara K; Batish SD; Hanenberg H; Auerbach AD
    Hum Mutat; 2005 Feb; 25(2):142-9. PubMed ID: 15643609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fanconi anaemia and leukaemia - clinical and molecular aspects.
    Tischkowitz M; Dokal I
    Br J Haematol; 2004 Jul; 126(2):176-91. PubMed ID: 15238138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical protocol for in vivo selection of hematopoietic stem cells corrected by gene therapy in Fanconi anemia group C.
    Noll M; Bateman RL; D'Andrea AD; Grompe M
    Mol Ther; 2001 Jan; 3(1):14-23. PubMed ID: 11162306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical and biological overlap between Nijmegen Breakage Syndrome and Fanconi anemia.
    Gennery AR; Slatter MA; Bhattacharya A; Barge D; Haigh S; O'Driscoll M; Coleman R; Abinun M; Flood TJ; Cant AJ; Jeggo PA
    Clin Immunol; 2004 Nov; 113(2):214-9. PubMed ID: 15451479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular study of Fanconi anemia in Tunisia].
    Bouchlaka C; Abdelhak S; Dellagi K;
    Tunis Med; 2004 May; 82(5):402-10. PubMed ID: 15453041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of three novel Fanconi anemia mutations in Israeli Arabs.
    Tamary H; Dgany O; Toledano H; Shalev Z; Krasnov T; Shalmon L; Schechter T; Bercovich D; Attias D; Laor R; Koren A; Yaniv I
    Eur J Haematol; 2004 May; 72(5):330-5. PubMed ID: 15059067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unrelated donor bone marrow transplantation for Fanconi anemia.
    Davies SM; Khan S; Wagner JE; Arthur DC; Auerbach AD; Ramsay NK; Weisdorf DJ
    Bone Marrow Transplant; 1996 Jan; 17(1):43-7. PubMed ID: 8673053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Favourable long-term outcome after matched sibling transplantation for Fanconi-anemia (FA) and in vivo T-cell depletion.
    Huck K; Hanenberg H; Nürnberger W; Dilloo D; Burdach S; Göbel U; Laws HJ
    Klin Padiatr; 2008; 220(3):147-52. PubMed ID: 18478486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecular basis of Fanconi's anemia].
    Digweed M
    Klin Padiatr; 1999; 211(4):192-7. PubMed ID: 10472548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of Fanconi anemia in patients with bone marrow failure.
    Pinto FO; Leblanc T; Chamousset D; Le Roux G; Brethon B; Cassinat B; Larghero J; de Villartay JP; Stoppa-Lyonnet D; Baruchel A; Socié G; Gluckman E; Soulier J
    Haematologica; 2009 Apr; 94(4):487-95. PubMed ID: 19278965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer in Fanconi anemia, 1927-2001.
    Alter BP
    Cancer; 2003 Jan; 97(2):425-40. PubMed ID: 12518367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.